Index
453
Oxygen reduction reaction, 39, 40, 50–56,
64, 174, 176, 180
P
P-activation of alkynes, 257
Palladium (Pd), 112, 115, 116, 118, 121–
123, 289, 304, 310, 313, 314, 316,
318, 320, 324, 326, 331, 334, 347,
353, 354, 356, 357, 364, 365, 379–
382
Palladium sulphide, 313
Paramagnetic intermediates, 272
Particle size, 303, 304, 307, 308, 327
Pd ALD, 75, 81
Pd/C, 289
PdCo NPs, 258, 259
Pd(hfac) 2 , 73, 75
Pd(II), 290
Pd nanoparticles, 228, 230–236, 238, 240,
241
Pd–N-heterocyclic carbene complexes, 259
Pd NPs, 259, 290, 291, 441, 442
PEG300, 259, 269
PEG-400, 260, 264
PEG-4000, 252
Peptides, 289, 293, 294
Phenanthroline, 116
Phenols, 261, 269, 271
Phosphide, 310, 315, 316
Phosphine, 291, 292
Phosphine ligands, 420, 423, 424
Phosphite ligands, 426, 435
Photocycloaddition, 166, 172
Piperazine, 326
–π interaction, 440
Platinum (Pt), 110, 112, 113, 116, 118, 120,
121, 294, 296, 297
Poisoning, 318, 327, 328, 333
Polyethylene Glycol (PEG), 252, 253, 255,
260, 261, 263, 269
Polyol medium, 269, 272
Polyvinyl alcohol, 251, 255
Poly(4-vinylpyridine) (PVPy), 415
Polyvinylpyrrolidone (PVP), 253, 266, 291–
294, 297, 416, 421, 422, 427
Porous coating, 89–91
PPh 2 H, 412
PPhH 2 , 412
Propargyl amines, 266, 268
Pt ALD, 75, 80, 96
Pt NPs, 414, 415, 431, 440
Pyrano[2,3-d]pyrimidines, 255
Pyrrolo[1,2-a]quinolines, 268
Q
Quantized electronic structure, 39
Quantum confinement, 39
Quinolines, 204, 208, 212, 266, 268
R
Reduced Graphene Oxide (rGO), 356, 357,
378, 379
Reductive amination, 201, 205, 207, 212,
214, 216
Reductive elimination, 286
Reductive N-methylation of nitroarenes,
201, 202
Reforming of methane, 82, 83, 86, 89, 90
Rh(acac) 3 , 73, 76
Rh ALD, 76
Rh NPs, 422, 426, 434
Rotary reactor, 95, 96
Ru/C, 289
Ru(COD)(COT), 417, 420, 423, 427, 434–
436
Ru(II), 288, 289
Ru NPs, 286, 292–294, 296, 408–410, 412–
432, 434, 436–442
RuNPs/ACC, 294
RuPt NPs, 296
Ru/PVP NPs, 291, 292
Ruthenium (Ru), 110–112, 115, 116, 120,
121, 123–125, 288, 289
S
SBA, 354–356, 373, 374, 381, 396, 397
Secondary Phosphine Oxides (SPO), 350–
352, 385, 425, 426, 435
Selective ALD, 80, 81, 90–93, 97
Semi-hydrogenation, 303–334
-bond metathesis, 299
Single atom, 77, 78
Single Atom Catalysts (SACs), 304, 308,
309
Single crystal X–ray diffraction, 11, 27, 33
SiO 2 , 354, 356, 359, 362–364, 369, 372, 374,
378, 383, 384, 386, 387, 393, 396,
410, 411
Site separation, 326
Size and shape effects, 308
Size control, 70, 71
Size effect, 41, 50, 51, 54, 64
Solid catalysts, 18
453
Oxygen reduction reaction, 39, 40, 50–56,
64, 174, 176, 180
P
P-activation of alkynes, 257
Palladium (Pd), 112, 115, 116, 118, 121–
123, 289, 304, 310, 313, 314, 316,
318, 320, 324, 326, 331, 334, 347,
353, 354, 356, 357, 364, 365, 379–
382
Palladium sulphide, 313
Paramagnetic intermediates, 272
Particle size, 303, 304, 307, 308, 327
Pd ALD, 75, 81
Pd/C, 289
PdCo NPs, 258, 259
Pd(hfac) 2 , 73, 75
Pd(II), 290
Pd nanoparticles, 228, 230–236, 238, 240,
241
Pd–N-heterocyclic carbene complexes, 259
Pd NPs, 259, 290, 291, 441, 442
PEG300, 259, 269
PEG-400, 260, 264
PEG-4000, 252
Peptides, 289, 293, 294
Phenanthroline, 116
Phenols, 261, 269, 271
Phosphide, 310, 315, 316
Phosphine, 291, 292
Phosphine ligands, 420, 423, 424
Phosphite ligands, 426, 435
Photocycloaddition, 166, 172
Piperazine, 326
–π interaction, 440
Platinum (Pt), 110, 112, 113, 116, 118, 120,
121, 294, 296, 297
Poisoning, 318, 327, 328, 333
Polyethylene Glycol (PEG), 252, 253, 255,
260, 261, 263, 269
Polyol medium, 269, 272
Polyvinyl alcohol, 251, 255
Poly(4-vinylpyridine) (PVPy), 415
Polyvinylpyrrolidone (PVP), 253, 266, 291–
294, 297, 416, 421, 422, 427
Porous coating, 89–91
PPh 2 H, 412
PPhH 2 , 412
Propargyl amines, 266, 268
Pt ALD, 75, 80, 96
Pt NPs, 414, 415, 431, 440
Pyrano[2,3-d]pyrimidines, 255
Pyrrolo[1,2-a]quinolines, 268
Q
Quantized electronic structure, 39
Quantum confinement, 39
Quinolines, 204, 208, 212, 266, 268
R
Reduced Graphene Oxide (rGO), 356, 357,
378, 379
Reductive amination, 201, 205, 207, 212,
214, 216
Reductive elimination, 286
Reductive N-methylation of nitroarenes,
201, 202
Reforming of methane, 82, 83, 86, 89, 90
Rh(acac) 3 , 73, 76
Rh ALD, 76
Rh NPs, 422, 426, 434
Rotary reactor, 95, 96
Ru/C, 289
Ru(COD)(COT), 417, 420, 423, 427, 434–
436
Ru(II), 288, 289
Ru NPs, 286, 292–294, 296, 408–410, 412–
432, 434, 436–442
RuNPs/ACC, 294
RuPt NPs, 296
Ru/PVP NPs, 291, 292
Ruthenium (Ru), 110–112, 115, 116, 120,
121, 123–125, 288, 289
S
SBA, 354–356, 373, 374, 381, 396, 397
Secondary Phosphine Oxides (SPO), 350–
352, 385, 425, 426, 435
Selective ALD, 80, 81, 90–93, 97
Semi-hydrogenation, 303–334
-bond metathesis, 299
Single atom, 77, 78
Single Atom Catalysts (SACs), 304, 308,
309
Single crystal X–ray diffraction, 11, 27, 33
SiO 2 , 354, 356, 359, 362–364, 369, 372, 374,
378, 383, 384, 386, 387, 393, 396,
410, 411
Site separation, 326
Size and shape effects, 308
Size control, 70, 71
Size effect, 41, 50, 51, 54, 64
Solid catalysts, 18